Abstract
We retrospectively evaluated the efficacy of immune tolerance induction (ITI) in a homogenous cohort of eight patients with constitutive severe hemophilia A with high-responding factor VIII (FVIII) inhibitors using Facteur VIII-LFB/Factane, a highly purified FVIII concentrate containing von Willebrand factor (VWF).
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Child
-
Child, Preschool
-
Factor VIII / antagonists & inhibitors*
-
Factor VIII / immunology*
-
Factor VIII / metabolism
-
Hemophilia A / blood
-
Hemophilia A / immunology*
-
Humans
-
Immune Tolerance*
-
Infant
-
Retrospective Studies
-
von Willebrand Diseases / blood
-
von Willebrand Diseases / immunology
-
von Willebrand Factor / antagonists & inhibitors*
-
von Willebrand Factor / immunology*
-
von Willebrand Factor / metabolism
Substances
-
von Willebrand Factor
-
Factor VIII